{"id":4059,"date":"2025-05-23T23:03:09","date_gmt":"2025-05-23T23:03:09","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2025\/05\/23\/pharma-biotech-jobs-inozyme-biohaven-pepgen-alios-prime\/"},"modified":"2025-05-23T23:03:09","modified_gmt":"2025-05-23T23:03:09","slug":"pharma-biotech-jobs-inozyme-biohaven-pepgen-alios-prime","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2025\/05\/23\/pharma-biotech-jobs-inozyme-biohaven-pepgen-alios-prime\/","title":{"rendered":"STAT+: Up and down the ladder: The latest comings and goings"},"content":{"rendered":"<p>    STAT+: Up and down the ladder: The latest comings and goings<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n    <!-- no image --><br \/>\n \t<BR><br \/>\n<BR><\/BR><\/p>\n<div>\n<p>Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we\u2019ll share it with others.\u00a0<strong>That\u2019s right.\u00a0Send us your changes, and we\u2019ll find\u00a0a home for them<\/strong>. Don\u2019t be shy. Everyone wants to know who is coming and going.<\/p>\n<p>And here is our regular feature in which we highlight a different person each week. This time around, we note that<strong> Inozyme Pharma<\/strong> promoted Petra Duda to chief medical officer from senior vice president of clinical development. Before joining Inozyme last year, she worked at UCB, where she was vice president, global development lead.<\/p>\n<p><strong>But all work and no play can make for a dull chief medical officer.<\/strong><\/p>\n<p><a href=\"https:\/\/www.statnews.com\/pharmalot\/2025\/05\/23\/pharma-biotech-jobs-inozyme-biohaven-pepgen-alios-prime\/?utm_campaign=rss\">Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n<p> \t<BR><br \/>\n <BR><\/BR><br \/>\n    Ed Silverman<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n<a href=\"https:\/\/www.statnews.com\/pharmalot\/2025\/05\/23\/pharma-biotech-jobs-inozyme-biohaven-pepgen-alios-prime\/?utm_campaign=rss\">Go to statnews<\/a><br \/>\n \t<BR><br \/>\n <BR><\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"<p>STAT+: Up and down the ladder: The latest comings and goings Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we\u2019ll share it with others.\u00a0That\u2019s right.\u00a0Send us your changes, and we\u2019ll find\u00a0a home for them. Don\u2019t be shy. Everyone wants to know who is [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2154,2155,2153,2152],"tags":[2150],"class_list":["post-4059","post","type-post","status-publish","format-standard","hentry","category-biotechnology","category-pharmaceuticals","category-pharmalot","category-stat","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/4059"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=4059"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/4059\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=4059"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=4059"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=4059"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}